3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Multiple Myeloma
6
Recurrence
2
Neoplasms, Plasma Cell
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Burkitt Lymphoma
2
Meningeal Carcinomatosis
1
Lymphoma
1
Lymphedema
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Disease Progression
1
Disease
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Pemetrexed
5
Topotecan
3
Dexamethasone
3
Bevacizumab
3
osimertinib
2
Vitamin B 12
2
Trastuzumab
2
Spinal Puncture
2
Radiotherapy
2
Methotrexate
2
Folic Acid
2
Cytarabine
2
Busulfan
2
trioctyl phosphine oxide
1
trastuzumab deruxtecan
1
tipifarnib
1
merphos
1
mafosfamide
1
immunotoxin LMB-7
1
epothilone B
1
avelumab
1
aflutinib
1
XL647
1
Transplantation, Autologous
1
Temozolomide
1
Rituximab
1
Referral and Consultation
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Mental Status and Dementia Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningeal Carcinomatosis
×
Transplantation, Autologous
×
Clear all
NCT00801216
2024-12-10
SCNSL1
IRCCS San Raffaele
Phase 2
Completed
40 enrolled
11 charts